Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Leite

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
Acta Neuropathologica Communications|December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody diseaseMaciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Brain : a Journal of Neurology|February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated diseaseWei Z Yeh, Anna Francis, Sarah Cooper, et al.
Multiple Sclerosis and Related Disorders|February 21, 2014
Treatment of Neuromyelitis Optica: Review and RecommendationsDorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, et al.
Practical Neurology|January 6, 2026
CAR-T cells in the treatment of neurological autoimmune diseasesFrederick W Vonberg, Benjamin E Schroeder, Amy Edwards, et al.
Neurology|January 14, 2014
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersDouglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto, et al.
Annals of Clinical and Translational Neurology|July 14, 2026
Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseValentina Camera, Agnese Tamanti, Silvia Messina, et al.
Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.
Multiple Sclerosis and Related Disorders|March 29, 2024
A study of referral bias in NMOSD and MOGAD cohortsMiguel Leal Rato, Bo Chen, Anna Francis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
The Lancet. Neurology|April 20, 2026
Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association studyKathrine E Attfield, Angelos P Armen, Subita Balaram Kuttikkatte, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Acta Neuropathologica Communications|December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody diseaseMaciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Brain : a Journal of Neurology|February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated diseaseWei Z Yeh, Anna Francis, Sarah Cooper, et al.
Multiple Sclerosis and Related Disorders|February 21, 2014
Treatment of Neuromyelitis Optica: Review and RecommendationsDorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, et al.
Practical Neurology|January 6, 2026
CAR-T cells in the treatment of neurological autoimmune diseasesFrederick W Vonberg, Benjamin E Schroeder, Amy Edwards, et al.
Neurology|January 14, 2014
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersDouglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto, et al.
Annals of Clinical and Translational Neurology|July 14, 2026
Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseValentina Camera, Agnese Tamanti, Silvia Messina, et al.
Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.
Multiple Sclerosis and Related Disorders|March 29, 2024
A study of referral bias in NMOSD and MOGAD cohortsMiguel Leal Rato, Bo Chen, Anna Francis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
The Lancet. Neurology|April 20, 2026
Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association studyKathrine E Attfield, Angelos P Armen, Subita Balaram Kuttikkatte, et al.
Pageof 19